The U.S. Navy sent a warship on Tuesday within 12 nautical miles of two artificial islands built by China in the South China Sea, a U.S. defence official told Reuters, in a challenge to China's territorial claims in the area.
US Navy begins patrol near China's man-made islands
"The operation has begun ... It will be complete within a few hours," said the official.
China says followed U.S. warship in South China Sea
Recommended articles
The official said the patrol was carried out by the destroyer USS Lassen near Subi and Mischief reefs in the Spratly archipelago, features that were formerly submerged at high tide before China began a massive dredging project to turn them into islands in 2014.
"The operation has begun ... It will be complete within a few hours," said the official.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
Repentant Boko Haram terrorist arrested for beating ex-wife to death
Gov Adeleke seeks TETFund's support on infrastructure in Osun
Sanwo-Olu considers reintroducing monthly environmental sanitation in Lagos
Constitutional role for traditional rulers, a necessity — AGF Fagbemi
Amosun's loyalists reconcile with Gov Abiodun, return to APC in Ogun
Abia govt to tackle perennial flooding in Ariaria Market
FG disappointed by slow progress on Port Harcourt-Maiduguri rail project
Enugu govt announces ₦26b investment in transport sector
Tinubu determined to turn Nigeria’s demographic bulge into dividends – Shettima
Pulse Sports
Super Falcons' Michelle Alozie drops football hot take
Kane defends Harry ‘One of the best defenders in history’ Maguire, calls for end to scapegoating
Provedel: 4 goalkeepers who have scored in the Champions League including Vincent Enyeama
Andre Onana: Critics of the Manchester United goalkeeper are missing the bigger picture
100 not out: Lewandowski moves closer to Messi and Ronaldo with century of European goals
Is Victor Osimhen in for a troubled season under Rudi Garcia?
ADVERTISEMENT
